Rights and permissions
About this article
Cite this article
Formulary switch from celecoxib to rofecoxib upsets BP. Pharmacoecon. Outcomes News 479, 4 (2005). https://doi.org/10.2165/00151234-200504790-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504790-00009